BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24659709)

  • 1. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.
    Liu MX; Siu MK; Liu SS; Yam JW; Ngan HY; Chan DW
    Oncotarget; 2014 Feb; 5(4):944-58. PubMed ID: 24659709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines].
    Feng Z; Wen H; Liao Q
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):780-6. PubMed ID: 25537253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF Signaling.
    Chen T; Margariti A; Kelaini S; Cochrane A; Guha ST; Hu Y; Stitt AW; Zhang L; Xu Q
    Stem Cells; 2015 May; 33(5):1405-18. PubMed ID: 25535084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway.
    Qu X; Chen Z; Fan D; Sun C; Zeng Y; Guo Z; Qi Q; Li W
    J Cell Mol Med; 2017 Jun; 21(6):1159-1170. PubMed ID: 27957826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis.
    Wang Y; Lin Q; Song C; Ma R; Li X
    Cell Cycle; 2020 Dec; 19(23):3289-3302. PubMed ID: 33131409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M; Xia B; Qin L; Chen H; Lou G
    DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-199b-5p promoted chondrogenic differentiation of C3H10T1/2 cells by regulating JAG1.
    Zhang M; Yuan SZ; Sun H; Sun L; Zhou D; Yan J
    J Tissue Eng Regen Med; 2020 Nov; 14(11):1618-1629. PubMed ID: 32870569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
    Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.
    Garzia L; Andolfo I; Cusanelli E; Marino N; Petrosino G; De Martino D; Esposito V; Galeone A; Navas L; Esposito S; Gargiulo S; Fattet S; Donofrio V; Cinalli G; Brunetti A; Vecchio LD; Northcott PA; Delattre O; Taylor MD; Iolascon A; Zollo M
    PLoS One; 2009; 4(3):e4998. PubMed ID: 19308264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer.
    Oktem G; Sanci M; Bilir A; Yildirim Y; Kececi SD; Ayla S; Inan S
    Int J Gynecol Cancer; 2012 Jan; 22(1):23-9. PubMed ID: 22080880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199b represses porcine muscle satellite cells proliferation by targeting JAG1.
    Zhu L; Hou L; Ou J; Xu G; Jiang F; Hu C; Wang C
    Gene; 2019 Apr; 691():24-33. PubMed ID: 30599234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
    Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
    Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1.
    Wang Y; Bao W; Liu Y; Wang S; Xu S; Li X; Li Y; Wu S
    Cell Death Dis; 2018 May; 9(5):447. PubMed ID: 29670086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells.
    Chen L; Holmstrøm K; Qiu W; Ditzel N; Shi K; Hokland L; Kassem M
    Stem Cells; 2014 Apr; 32(4):902-12. PubMed ID: 24307639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
    Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
    Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.